{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-26-347825","form_type":"8-K","ticker":"SBC","cik":"0001930313","company_name":"SBC Medical Group Holdings Inc","filed_at":"2026-08-13T10:50:16+00:00","discovered_at":"2026-08-13T10:55:00.567341+00:00","generated_at":"2026-08-13T10:55:07.110892+00:00","sec_items":["2.02","7.01","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.8,"calibrated_materiality_score":0.8,"confidence":"high","headline":"SBC Medical Q2 revenue up 13% to $49M; net income up 335% to $11M","bullets":["Total revenues $49M, +13% YoY; net income attributable $11M, +335% YoY; basic EPS $0.10, +400%.","Adjusted EBITDA $20M, +32% YoY; margin 41%, +6pts; net income margin 22%, +16pts.","Locations up 34 YoY to 287; LTM visits 6.9M (+10%); avg spend per visit $287 (+9%).","CEO cites AI-enabled fee increases; expects ~$15M annual service fee uplift from recent revisions.","Cash and equivalents $184M; plans OrangeTwist US collaboration, ASEAN expansion, Longevity entry."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-26-347825","json":"https://secwatch.observer/filing/0001193125-26-347825.json","markdown":"https://secwatch.observer/filing/0001193125-26-347825.md","text":"https://secwatch.observer/filing/0001193125-26-347825.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1930313/000119312526347825/0001193125-26-347825-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1930313/000119312526347825/sbc-20260813.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-08-13T10:55:07.110892+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}